WO2003013558A8 - Treatment of radiation-induced diarrhea with probiotics - Google Patents

Treatment of radiation-induced diarrhea with probiotics

Info

Publication number
WO2003013558A8
WO2003013558A8 PCT/IT2002/000494 IT0200494W WO03013558A8 WO 2003013558 A8 WO2003013558 A8 WO 2003013558A8 IT 0200494 W IT0200494 W IT 0200494W WO 03013558 A8 WO03013558 A8 WO 03013558A8
Authority
WO
WIPO (PCT)
Prior art keywords
probiotics
radiation
treatment
induced diarrhea
lactobacilli
Prior art date
Application number
PCT/IT2002/000494
Other languages
French (fr)
Other versions
WO2003013558A1 (en
Inventor
Simone Claudio De
Original Assignee
Simone Claudio De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simone Claudio De filed Critical Simone Claudio De
Priority to AU2002329043A priority Critical patent/AU2002329043A1/en
Publication of WO2003013558A1 publication Critical patent/WO2003013558A1/en
Publication of WO2003013558A8 publication Critical patent/WO2003013558A8/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Inflammatory conditions in the intestinal mucosa are prevented or treated with a dietary or pharmaceutical probiotic composition containing protective Streptococci, Lactobacilli and Bifidobacteria in a daily amount of from lOO to 3,600 x 109 bacteria cells.
PCT/IT2002/000494 2001-07-30 2002-07-26 Treatment of radiation-induced diarrhea with probiotics WO2003013558A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002329043A AU2002329043A1 (en) 2001-07-30 2002-07-26 Treatment of radiation-induced diarrhea with probiotics

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30811701P 2001-07-30 2001-07-30
US60/308,117 2001-07-30

Publications (2)

Publication Number Publication Date
WO2003013558A1 WO2003013558A1 (en) 2003-02-20
WO2003013558A8 true WO2003013558A8 (en) 2003-08-14

Family

ID=23192625

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT2002/000494 WO2003013558A1 (en) 2001-07-30 2002-07-26 Treatment of radiation-induced diarrhea with probiotics

Country Status (3)

Country Link
AR (1) AR034920A1 (en)
AU (1) AU2002329043A1 (en)
WO (1) WO2003013558A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018112739A1 (en) * 2016-12-20 2018-06-28 深圳华大基因研究院 Bifidobacterium pseudocatenulatum, culture method therefor and application thereof

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481681A1 (en) * 2003-05-30 2004-12-01 Claudio De Simone Lactic acid bacteria combination and compositions thereof
FR2875406B1 (en) * 2004-09-21 2007-01-05 Danisco STRAIN OF LACTOBACILLUS ACIDOPHILUS HAVING ANALGESIC PROPERTIES AT THE GASTROINTESTINAL SYSTEM LEVEL
WO2008064521A1 (en) * 2006-11-30 2008-06-05 Pharmapep Research & Development (Shenzhen) Co., Ltd. Lactobacillus fermentum cms-h002 and use thereof
EP2251019B1 (en) * 2008-01-15 2013-05-22 Sapporo Breweries Limited Agent for prevention of alcoholic hepatopathy
FI20096400A0 (en) * 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Use of blood group status I
EP2228067B1 (en) * 2010-02-22 2013-12-11 LR Health & Beauty Systems GmbH Probiotic compound and use of same
KR102157718B1 (en) * 2010-07-26 2020-09-18 큐 바이올로직스 인코포레이티드 Immunogenic anti-inflammatory compositions
CN104398538A (en) * 2014-10-28 2015-03-11 大连医科大学 Composite probiotics preparation for mitigating chemotherapy side effect
CN112236154B (en) * 2018-05-31 2024-10-18 深圳华大生命科学研究院 A composition and its application
CN111248443A (en) * 2020-03-10 2020-06-09 安徽大学 A kind of synbiotic composition with improving ulcerative colitis and its preparation and application
CN117603842B (en) * 2023-10-17 2024-07-05 健合香港有限公司 Composite microbial agent and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
IT1307850B1 (en) * 1999-03-15 2001-11-19 Italmed Di Galli Giovanna E Pa PHARMACEUTICAL COMPOSITION BASED ON LACTIC FERMENTS AND NON-ABSORBABLE CARBOHYDRATIN CONTAINING A CALCIUM SALT AND AN ALUMINUM SALT

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018112739A1 (en) * 2016-12-20 2018-06-28 深圳华大基因研究院 Bifidobacterium pseudocatenulatum, culture method therefor and application thereof

Also Published As

Publication number Publication date
AU2002329043A1 (en) 2003-02-24
WO2003013558A1 (en) 2003-02-20
AR034920A1 (en) 2004-03-24

Similar Documents

Publication Publication Date Title
EP0861905A3 (en) Novel lactobacilli strains useful in the treatment of disorders of the gastrointestinal system
WO2000072855A3 (en) Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
WO2002060276A8 (en) Combination of probiotics
BR0211441A (en) Lactobaciillus salivarius strains probiotics
WO2003033681A3 (en) Composition comprising a lactobacillus pentosus strain and uses thereof
CA2254548A1 (en) Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections
WO2003013558A8 (en) Treatment of radiation-induced diarrhea with probiotics
TR200101699T2 (en) Oral lactobacilli application for the prevention and treatment of urogenital infections
HUP0100428A3 (en) Strain of bacteria of the species lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain
EP1143985A3 (en) Use of lactobacillus salivarius
WO2005063200A3 (en) Probiotic tablet formulations
GB0027761D0 (en) Nutritional composition for an immune condition
MXPA04005346A (en) Use of micro-organisms for a directed delivery of substances to specific parts of the gut.
CA2258503A1 (en) Lectin compositions and uses thereof
MY140870A (en) Nutrition supplement containing lactobacillus acidophilus, yeast and soy protein
ATE221783T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LACTOBACILLUS PLANTARUM AND ARGININE
CA2294670C (en) Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora
CA2388952A1 (en) Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis
AU2001296939A1 (en) Oral delivery method and composition for solid medications or dietary supplements in the form of solid particles
EP1405641A3 (en) Pharmaceutical and/or nutraceutical composition comprising a combination of probiotic non sporogenic microorganisms and spores of Bacillus subtilis and/or Bacillus clausii
EE200300220A (en) Method for screening probiotic strains of the Bifidobacterium family
MD1853G2 (en) Microbial eubiotic preparation for prophylaxis and treatment of the intestinal disbacteriosis
IT1274733B (en) Strain of the genus Lactobacillus of human origin and its uses
HK1031685A (en) Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 08/2003 UNDER (30) REPLACE "06/308,117" BY "60/308,117"

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP